Plus   Neg

Lilly To Present Data Across Its Oncology Product Portfolio

Eli Lilly and Co. (LLY) said that it will present data from a number of studies across its oncology product portfolio at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, September 27 - October 1, 2019.

Lilly said it continues to investigate Verzenio (abemaciclib) across the breast cancer continuum to provide physicians with the information they need as they seek to optimize treatment options for those living with this devastating, complex disease.

In a late-breaking oral presentation, Lilly will share the registrational results of selpercatinib (LOXO-292) in RET-altered thyroid cancers, from the Phase 1/2 LIBRETTO-001 study.

Selpercatinib is a highly selective and potent, oral investigational new medicine being studied for the treatment of advanced cancers that develop due to alterations of the RET kinase.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
Follow RTT